HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 92/4/1982    most recent 00411.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Heinricher, M. M. Articles by Neubert, M. J. Search for Related Content PubMed PubMed Citation Articles by Heinricher, M. M. Articles by Neubert, M. J.

Neural Basis for the Hyperalgesic Action of Cholecystokinin in the Rostral Ventromedial Medulla

Department of Neurological Surgery, Oregon Health and Science University, Portland, Oregon 97239

Submitted 21 April 2004; accepted in final form 18 May 2004

The analgesic actions of opioids can be modified by endogenous "anti-opioid" peptides, among them cholecystokinin (CCK). CCK is now thought to have a broader, pronociceptive role, and contributes to hyperalgesia in inflammatory and neuropathic pain states. The aim of this study was to determine whether anti-opioid and pronociceptive actions of CCK have a common underlying mechanism. We showed previously that a low dose of CCK microinjected into the rostral ventromedial medulla (RVM) blocked the analgesic effect of systemically administered morphine by preventing activation of OFF-cells, which are the antinociceptive output of this well characterized pain-modulating region. At this anti-opioid dose, CCK had no effect on the spontaneous activity of these neurons or on the activity of ON-cells (hypothesized to facilitate nociception) or "NEUTRAL cells" (which have no known role in pain modulation). In this study, we used microinjection of a higher dose of CCK into the RVM to test whether activation of ON-cells could explain the pronociceptive action of this peptide. Paw withdrawal latencies to noxious heat and the activity of a characterized RVM neuron were recorded in rats lightly anesthetized with methohexital. CCK (30 ng/200 nl) activated ON-cells selectively and produced behavioral hyperalgesia. Firing of OFF-cells and NEUTRAL cells was unaffected. These data show that direct, selective activation of RVM ON-cells by CCK is sufficient to produce thermal hyperalgesia and indicate that the anti-opioid and pronociceptive effects of this peptide are mediated by actions on different RVM cell classes.

This article has been cited by other articles:

				M. P. Davis and M. Angst In Reply J. Clin. Oncol., July 10, 2008; 26(20): 3465 - 3465. [Full Text] [PDF]

				M. P. Davis and M. Angst In Reply J. Clin. Oncol., March 20, 2008; 26(9): 1565 - 1565. [Full Text] [PDF]

				J. D. Carlson, J. J. Maire, M. E. Martenson, and M. M. Heinricher Sensitization of Pain-Modulating Neurons in the Rostral Ventromedial Medulla after Peripheral Nerve Injury J. Neurosci., November 28, 2007; 27(48): 13222 - 13231. [Abstract] [Full Text] [PDF]

				D. Budai, S. G. Khasabov, P. W. Mantyh, and D. A. Simone NK-1 Receptors Modulate the Excitability of ON Cells in the Rostral Ventromedial Medulla J Neurophysiol, February 1, 2007; 97(2): 1388 - 1395. [Abstract] [Full Text] [PDF]

				W. Kincaid, M. J. Neubert, M. Xu, C. J. Kim, and M. M. Heinricher Role for Medullary Pain Facilitating Neurons in Secondary Thermal Hyperalgesia J Neurophysiol, January 1, 2006; 95(1): 33 - 41. [Abstract] [Full Text] [PDF]

				J. Y. Xie, D. S. Herman, C.-O. Stiller, L. R. Gardell, M. H. Ossipov, J. Lai, F. Porreca, and T. W. Vanderah Cholecystokinin in the Rostral Ventromedial Medulla Mediates Opioid-Induced Hyperalgesia and Antinociceptive Tolerance J. Neurosci., January 12, 2005; 25(2): 409 - 416. [Abstract] [Full Text] [PDF]